PharmacoPlatform: ICH E2B(R3) ICSR-Gateways, Disproportionalitäts-Scoring & Sicherheits-Signal-Mining
PharmacoPlatform liefert Enterprise-Pharmakovigilanz (PV)-Softwarearchitekturen zur Automatisierung von ICSR-Erfassungen, NLP-basierter Extraktion medizinischer unerwünschter Ereignisse aus Spontanmeldungen und Disproportionalitäts-Signalerkennung nach FDA FAERS und EMA EudraVigilance.
PharmacoPlatform Global Pharmacovigilance & Signal Detection Pipeline
Multichannel safety intake, MedDRA NLP normalization, and disproportionality scoring
Central System: Pharmacovigilance Core - E2B(R3) Engine & Disproportionality Analyzer
Clinical IoMT Nodes
- Multichannel Safety Intake Sink
- Clinical NLP / MedDRA Auto-Coder
- Individual Case Safety Report (ICSR) Core
- Disproportionality Signal Engine
- Regulatory Gateway Dispatcher
Architectural Layers & Regulatory Standards
- Multisource Adverse Event Ingestion (Optical Character Recognition (OCR) / Multi-Tenant Intake APIs): Ingesting adverse event reports from clinical trials, spontaneous patient hotlines, scientific literature, and social platforms.
- Medical Ontology Normalization (Clinical Transformer Models / MedDRA Dictionary v26+): Mapping unstructured patient symptom descriptions into standardized Medical Dictionary for Regulatory Activities (MedDRA) terms.
- Statistical Signal Detection & Disproportionality (Bayesian Confidence Propagation Neural Network (BCPNN)): Computing Proportional Reporting Ratios (PRR) and empirical Bayes geometric means to detect emerging safety signals.
- Automated Regulatory Electronic Submission (AS2 Secure Gateway / E2B(R3) XML Validator): Validating and transmitting expedited 7-day and 15-day safety reports to FDA FAERS and EudraVigilance.
Key Metrics: < 15 min (Automated ICSR Processing Time) | 99.4% (MedDRA Coding Accuracy) | 100% (ICH E2B(R3) XML Schema Compliance) | Real-Time (Adverse Signal Disproportionality Mining)
Automatisierte Pharmakovigilanz, E2B(R3)-Sicherheitsberichterstattung und Erkennung von Signalen unerwünschter Arzneimittelwirkungen (ADR)
Autoritative technische Referenz fuer automated pharmacovigilance, e2b(r3) safety reporting & adverse drug reaction (adr) signal detection gemaess FDA 510(k), EU MDR, IEC 62304 Klasse C Software-Lebenszyklus und IoMT-Interoperabilitaet.
Core Engineering Areas
Technical Articles
Related Cluster Architecture Specifications
- HealthVigilance — Zero-Trust IoMT Architecture, SaMD Risk Engineering & Autonomous Clinical Post-Market Vigilance
- AgenticSaMD — Autonomous Agentic Software as a Medical Device, Multi-Agent Clinical Decision Support & FDA GMLP Guardrails
- AITelemonitoring — Autonomous AI Telemonitoring, Virtual Nursing Assistants & Predictive Clinical Deterioration Scoring
- BCI2IoMT — Brain-Computer Interface IoMT Gateways, Neural Decoding & Electrophysiological Streaming